Children Allergic Rhinitis
Conditions
Interventions
Experimental group:Yiqi Jianpi Tongqiao decoction
Sponsors
The Affiliated Hospital of Qingdao University
Eligibility
Sex/Gender
All
Age
5 Years to 14 Years
Inclusion criteria
Inclusion criteria: (1) those who met the diagnostic criteria of allergic rhinitis, lung and Spleen Qi Deficiency Syndrome in children and the diagnostic criteria of western medicine in children's allergic rhinitis. (2) the age of the children ranged from 5 to 14 years. (3) the parents knew and agreed to participate in the clinical study. (4) the children could persist in the treatment and have good compliance, and could persist in the outpatient treatment for at least 2 weeks.
Exclusion criteria
Exclusion criteria: (1) persons who are known to be allergic to this drug or are receiving any medication or immunotherapy. (2) patients with AR-like symptoms caused by other diseases such as upper respiratory tract infection. (3) children with severe complications of AR, such as acute asthma, severe deviated Septum, and sleep apnea syndrome, require surgical treatment. (4) patients with severe diseases of heart, liver, kidney and other organs. (5) the allergic rhinitis had received relevant medical treatment or operation within 1 week after the onset of the disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main symptom score;Secondary symptom score;life quality score; | — |
Secondary
| Measure | Time frame |
|---|---|
| IL-4;IFN-?; | — |
Countries
China
Contacts
Public ContactZhou Jie
The Affiliated Hospital of Qingdao University
Outcome results
None listed